Table 2.
Authors | Risk Factor | Number of Patients |
---|---|---|
Ishihara et al. [86] | Metabolic Syndrome (Obesity and Hyperlipidemia) | 166 |
Yildirim et al. [46] | Metabolic Syndrome | 199 |
Theyskens et al. [13] | Cushing’s Syndrome * | 731 |
Bhatia et al. [39] | Cushing’s Syndrome * | 1 |
Ahmad et al. [40] | Cushing’s Disease * | 1 |
Ishihara et al. [82] | Hyperlipidemia * | 324 |
Zhang et al. [41] | Obesity * | 807 |
Cushnie et al. [87] | Obesity * | 99 |
Walker et al. [88] | Obesity * | 25 |
Fogel et al. [2] | Obesity * | 104 |
Spinnato et al. [45] | Obesity * | 1 |
Sasagasako et al. [89] | Subcutaneous Fat Thickness * | 500 |
Lotan et al. [67] | Diabetes Type 1 * | 3 |
Park et al. [90] | Diabetes Type 2 * | 42 |
Morishita et al. [91] | Visceral Fat * | 218 |
Abe et al. [48] | NAFLD * | 102 |
Okada et al. [61] | DISH * | 327 |
Khawaja et al. [7] | Hypertension * | 2 |
Fasset et al. [16] | Exogenous Steroids | 2 |
Tok et al. [92] | Epidural Steroid Injection | 1 |
Billings et al. [49] | HAART-associated Lipodystrophy | 1 |
Mattei et al. [53] | Androgen Deprivation Therapy | 1 |
Papastefan et al. [9] | Idiopathic | 1 |
Stern et al. [31] | Idiopathic | 2 |